Cataract Therapeutic Pipeline Market Review by Companies and Drugs H2 2014 Report at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds Cataract Pipeline Review, H2 2014 market research report of 46 pages to the Cataract drugs industry and company profiles research collection of its business intelligence library.

Cataract Therapeutic Pipeline Market

Cataract Therapeutic Pipeline Market

The report “Cataract – Pipeline Review, H2 2014” provides comprehensive information on the therapeutic development for Cataract, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cataract and special features on late-stage and discontinued projects. Complete Report is Available @ http://www.rnrmarketresearch.com/cataract-pipeline-review-h2-2014-market-report.html .

A cataract is a clouding of the lens inside the eye which leads to a decrease in vision. Cataracts are the most common cause of vision loss in people over age 40 and is the principal cause of blindness in the world. Visual loss occurs because opacification of the lens obstructs light from passing and being focused on the retina at the back of the eye. Companies discussed in this Cataract therapy Pipeline market report include CalAsia Pharmaceuticals, Inc., EyeGate Pharmaceuticals, Inc., InSite Vision Incorporated, Laboratorios Sophia S.A. de C.V., Laila Pharmaceuticals Pvt. Ltd.

Types of cataracts include:

  •     Subcapsular Cataract
  •     Nuclear Cataract
  •     Cortical Cataract

Order a Purchase copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=242166 .

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope of the report as follows: The report provides a snapshot of the global therapeutic landscape of Cataract. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Cataract and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects. A review of the Cataract products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects. Coverage of the Cataract pipeline on the basis of target, MoA, route of administration and molecule type. Latest news and deals relating related to pipeline products. Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=242166 .

List of Table & Figures include in this reports are

List of Tables
Number of Products under Development for Cataract, H2 2014
Number of Products under Development for Cataract - Comparative Analysis, H2 2014
Number of Products under Development by Companies, H2 2014
Number of Products under Investigation by Universities/Institutes, H2 2014
Comparative Analysis by Clinical Stage Development, H2 2014
Comparative Analysis by Early Stage Development, H2 2014
Products under Development by Companies, H2 2014
Products under Investigation by Universities/Institutes, H2 2014
Cataract - Pipeline by CalAsia Pharmaceuticals, Inc., H2 2014
Cataract - Pipeline by EyeGate Pharmaceuticals, Inc., H2 2014
Cataract - Pipeline by InSite Vision Incorporated, H2 2014
Cataract - Pipeline by Laboratorios Sophia S.A. de C.V., H2 2014
Cataract - Pipeline by Laila Pharmaceuticals Pvt. Ltd., H2 2014
Assessment by Monotherapy Products, H2 2014
Assessment by Combination Products, H2 2014
Number of Products by Stage and Target, H2 2014
Number of Products by Stage and Mechanism of Action, H2 2014
Number of Products by Stage and Route of Administration, H2 2014
Number of Products by Stage and Molecule Type, H2 2014
Cataract Therapeutics - Recent Pipeline Updates, H2 2014
Cataract - Dormant Projects, H2 2014
Cataract - Discontinued Products, H2 2014

Explore more reports on Ophthalmology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics .

About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@chinamrreport
Follow >
ReportsnReports
Like >
Follow us on
Visit website